German personal care giant Evonik has invested in Chinese vegan collagen maker Jland Biotech as part of a partnership to develop new products.
Financial details was not disclosed but Evonik said it has invested via its venture capital group through Jland Biotech's series round-B financing.
In addition, the two companies have signed a business cooperation agreement that will focus on the development and restructuring of new collagen protein products.
The partnership will enable Evonik to provide commercial quantities of collagen for applications in skincare such as anti-ageing and hydrating creams.
The new collagen products, manufactured in collaboration with Jland, will be launched later this year, expanding Evonik’s existing product portfolio of vegan collagen.
Evonik recently launched its own vegan collagen Vecollage Fortify L for cosmetic and personal care applications.
“Evonik’s life sciences division is using its biotechnology platform to leverage the expertise of its partners and collaborate on precision biosolutions. We welcome Jland to our partner network,” said Johann-Caspar Gammelin, Evonik’s president of its Nutrition & Care division.
“Together with our expertise in active ingredients and delivery systems, we are creating a world-leading portfolio of non-animal derived collagen,” he added.
Jland Biotech is a company dedicated to developing and manufacturing non-animal-derived collagen. It was founded in 2015 and has its headquarters in Jingjiang, China.
Jland’s core technology is centred around a production process that incorporates efficiency and scalability.
It develops collagen with multiple cosmetic, medical and food applications. The cosmetic range of collagen is fully registered with the Vegan Society.
“We value Jland’s outstanding approach to innovation and look forward to helping our customers develop the science-based, sophisticated beauty solutions that consumers worldwide are looking for,” said Yann d'Hervé, Head of Evonik's Care Solutions business line.
